Clinical trial · Observational
Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma
NCT02613156CI-TRIAL-00020437completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is aiming to evaluate the clinical efficacy of complete laparoscopic resection of recurrent hepatocellular carcinoma (HCC).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Recurrent Hepatocellular Carcinoma | Hepatocellular Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laparoscopic resection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- laparoscopic group
- description
- patients in the laparoscopic group underwent laparoscopic resection of recurrent HCC
- interventionNames
- Procedure: laparoscopic resection
- label
- control group
- description
- patients in the control group underwent conventional open surgery
Primary outcomes (1)
- measure
- Perioperative complications
- timeFrame
- within the first 30 days
- description
- The operation time, intraoperative blood loss, shortest distance between the tumor edge and normal liver tissue, postoperative pain scores, postoperative time until the patient could walk, postoperative time until the patient could pass gas, hospital stay, and inpatient costs were compared between the two groups.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. recurrent HCC after open surgery 2. recurrent HCC located in any part of the left lateral lobe or the diaphragm side of the right lobe and near the surface of the liver, which resulted in an easier operation 3. no significant surgical contraindications 4. no major vessel or bile duct tumor invasion and metastasis 5. grade A or B liver function or grade C liver function that recovered to grade A after liver-protective treatment; 6. the patient and his/her family was willing to undergo laparoscopic resection. Exclusion Criteria: 1. major vessel or bile duct tumor invasion 2. recurrent HCC located in the right liver parenchyma and near secondary vessels and bile ducts, resulting in a difficult operation 3. grade C liver function 4. significant surgical contraindications 5. the patient and his/her family declined laparoscopic hepatectomy.
References
Publications (0)
Data not yet available
No reference posted for this study.